Botox ®
 
 
 

What is BOTOX® Cosmetic?

BOTOX® Cosmetic is the product name for cosmetic wrikle removing drug. BOTOX®

In April of 2002 BOTOX® Cosmetic was first approved by the U.S. Food and Drug Administration (FDA)

Within a few hours to a couple of days after the botulinum toxin is injected into the affected muscle(s), the spasms or contractions are reduced or eliminated altogether. The effects of BOTOX® Cosmetic are not permanent, reportedly lasting anywhere from three to eight months. By injecting the toxin directly into a certain muscle or muscle group, the risk of When BOTOX® Cosmetic -- botulinum toxin A -- is injected into the muscles surrounding the eyes, for instance, those muscles can not "scrunch up" for a period of time. They are paralyzed. So the wrinkles in that area, often referred to as "crow's-feet," temporarily go away.


Side effect of Botox

Typically the amount of BOTOX® and side effects and BOTOX® danger remains low. Any BOTOX® side effects can typically only last 6 months at a
maximum,because BOTOX® treatments are temporary. People with neuromuscular disorders should consult with their physician carefully before having a BOTOX® injection treatment, as cardiovascular problems may arise. Likewise, those with cardiovascular disease should also pay special attention.

Some patients have been known to experience the side effects of BOTOX® of bruisng at the site of the injection. The most common BOTOX® side effects following the use of BOTOX® Cosmetic for glabellar lines are headache (13.3%), respiratory infection (3.5%), temporary eyelid droop (3.2%), nausea (3.0%), and flu syndrome (2.0%). Blepharoptosis is consistent with the pharmacologic action of BOTOX® Cosmetic and may be technique related. In rare occurences BOTOX® cosmetic can spread into neighboring muscles and cause temporary paralysis. In less that 1% of patients, this can cause drooping of the eyelid.

Less frequently side effects of BOTOX® occurring (<3%) adverse reactions included pain in the face, erythema at the injection site, and muscle weakness. These events are thought to be associated with the injection and occurred within the first week.